A survey of bisphosphonate-related osteomyelitis/osteonecrosis of the jaws

Bisphosphonates are used for the management of bone metastatic disease and hypercalcemia caused by malignancy, as well as the treatment of osteoporosis. Recently, a number of patients with bisphosphonate-associated osteomyelitis and osteonecrosis of the jaws have been reported in the English-languag...

Full description

Saved in:
Bibliographic Details
Published inJapanese Journal of Oral and Maxillofacial Surgery Vol. 53; no. 10; pp. 594 - 602
Main Authors ARIYOSHI, Yasunori, MORITA, Syosuke, FURUSAWA, Kiyofumi, IMAI, Yutaka, SHIMADA, Jun, UEYAMA, Yoshiya, SHIMAHARA, Masashi, MIZUKI, Harumi
Format Journal Article
LanguageEnglish
Published Japanese Society of Oral and Maxillofacial Surgeons 2007
Subjects
Online AccessGet full text
ISSN0021-5163
2186-1579
DOI10.5794/jjoms.53.594

Cover

Abstract Bisphosphonates are used for the management of bone metastatic disease and hypercalcemia caused by malignancy, as well as the treatment of osteoporosis. Recently, a number of patients with bisphosphonate-associated osteomyelitis and osteonecrosis of the jaws have been reported in the English-language literature. This report describes patients with bisphosphonate-related osteomyelitis and osteonecrosis of the jaws in Japan. The subjects were enrolled using questionnaires sent to 239 institutions certified as training facilities by the Japanese Society of Oral and Maxillofacial Surgeons in 2006. Thirty patients (4 men and 26 women) from 18 different institutions (mean age at diagnosis, 66.9 years) were studied. As for local features, pain with or without swelling was the most common symptom and sign. The mandible was affected in 22 patients, the maxilla in 6, and both jaws in 2. Twenty patients received intravenous bisphosphonates, 8 received only oral bisphosphonates, and 1 received both types of treatment. The reasons for bisphosphonate treatment were bone metastasis from breast carcinoma (13 patients), multiple myelomas (6 patients), osteoporosis (8 patients), and hypercalcemia related to malignancy. More than 50 % of the patients underwent oral surgery including tooth extraction just before or during treatment with bisphosphonates, while 5 patients received no dental treatment. In addition to antibiotic therapy, surgery, including sequestrectomy and curettage, was performed. As for outcome, 8 of the patients were completely cured, while 17 patients remained under treatment at the time of this writing.
AbstractList Bisphosphonates are used for the management of bone metastatic disease and hypercalcemia caused by malignancy, as well as the treatment of osteoporosis. Recently, a number of patients with bisphosphonate-associated osteomyelitis and osteonecrosis of the jaws have been reported in the English-language literature. This report describes patients with bisphosphonate-related osteomyelitis and osteonecrosis of the jaws in Japan. The subjects were enrolled using questionnaires sent to 239 institutions certified as training facilities by the Japanese Society of Oral and Maxillofacial Surgeons in 2006. Thirty patients (4 men and 26 women) from 18 different institutions (mean age at diagnosis, 66.9 years) were studied. As for local features, pain with or without swelling was the most common symptom and sign. The mandible was affected in 22 patients, the maxilla in 6, and both jaws in 2. Twenty patients received intravenous bisphosphonates, 8 received only oral bisphosphonates, and 1 received both types of treatment. The reasons for bisphosphonate treatment were bone metastasis from breast carcinoma (13 patients), multiple myelomas (6 patients), osteoporosis (8 patients), and hypercalcemia related to malignancy. More than 50 % of the patients underwent oral surgery including tooth extraction just before or during treatment with bisphosphonates, while 5 patients received no dental treatment. In addition to antibiotic therapy, surgery, including sequestrectomy and curettage, was performed. As for outcome, 8 of the patients were completely cured, while 17 patients remained under treatment at the time of this writing.
Author MORITA, Syosuke
IMAI, Yutaka
MIZUKI, Harumi
SHIMADA, Jun
SHIMAHARA, Masashi
FURUSAWA, Kiyofumi
UEYAMA, Yoshiya
ARIYOSHI, Yasunori
Author_xml – sequence: 1
  fullname: ARIYOSHI, Yasunori
  organization: Department of Dentistry and Oral Surgery, Division of Surgery 2, Osaka Medical College
– sequence: 1
  fullname: MORITA, Syosuke
  organization: First Department of Oral and Maxillofacial Surgery, Osaka Dental University
– sequence: 1
  fullname: FURUSAWA, Kiyofumi
  organization: Department of Oral and Maxillofacial Surgery, Matsumoto Dental University
– sequence: 1
  fullname: IMAI, Yutaka
  organization: Department of Oral and Maxillofacial Surgery, Dokkyo University School of Medicine
– sequence: 1
  fullname: SHIMADA, Jun
  organization: Division of First Oral and Maxillofacial Surgery, Department of Diagnosis and Therapeutics, Meikai University School of Dentistry
– sequence: 1
  fullname: UEYAMA, Yoshiya
  organization: Department of Oral and Maxillofacial Surgery, Yamaguchi University of Medicine
– sequence: 1
  fullname: SHIMAHARA, Masashi
  organization: Department of Dentistry and Oral Surgery, Division of Surgery 2, Osaka Medical College
– sequence: 1
  fullname: MIZUKI, Harumi
  organization: First Department of Oral and Maxillofacial Surgery, School of Dentistry, Iwate Medical University
BookMark eNp1kE1OwzAQhS1UJErpjgPkAKT43_GyqqCAKrGBdeS4E-oojSvbgHp7kgZYILGYGY3me0-jd4kmne8AoWuCF0Jpfts0fh8Xgi2E5mdoSkkhc9JfJmiKMSW5IJJdoHmMDcaYKE6p5FP0tMzie_iAY-brrHLxsPNDdSZBHqDtxzbzMYHfH6F1ycXb09aBDT66OKjSDrLGfMYrdF6bNsL8e87Q6_3dy-oh3zyvH1fLTW4p0zwHVnApt0ZpXROLQTBMtMK6KkxFGN1WllphKyxVjSuhBBS8kgJLqCnlteVshujoO7wQA9Sldckk57sUjGtLgsshkPIUSClY2QfSi27-iA7B7U04_oevR7yJybzBL2xCcraFESZaqkEwOIy9t_kh7M6EEjr2Bbs5f_s
CitedBy_id crossref_primary_10_2485_jhtb_22_141
crossref_primary_10_1016_j_jds_2022_10_030
crossref_primary_10_15214_jsodom_30_300
crossref_primary_10_1016_j_ajodo_2012_05_019
crossref_primary_10_3919_jjsa_70_1319
crossref_primary_10_3919_jjsa_69_3084
crossref_primary_10_1002_pds_3562
crossref_primary_10_1016_j_joms_2011_03_051
crossref_primary_10_2504_kds_64_208
crossref_primary_10_1016_j_joms_2018_04_009
crossref_primary_10_15214_jsodom_28_129
crossref_primary_10_1016_j_ajoms_2010_05_002
crossref_primary_10_5794_jjoms_55_354
ContentType Journal Article
Copyright Japanese Society of Oral and Maxillofacial Surgeons
Copyright_xml – notice: Japanese Society of Oral and Maxillofacial Surgeons
DBID AAYXX
CITATION
DOI 10.5794/jjoms.53.594
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
EISSN 2186-1579
EndPage 602
ExternalDocumentID 10_5794_jjoms_53_594
article_jjoms1967_53_10_53_10_594_article_char_en
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
F5P
JSF
KQ8
RJT
AAYXX
CITATION
ID FETCH-LOGICAL-c2394-e38466da799f1c0e53019709b8ab132dbc2c5cb067f0b575e84b6506ef224fc43
ISSN 0021-5163
IngestDate Tue Jul 01 02:16:52 EDT 2025
Thu Apr 24 23:01:45 EDT 2025
Wed Sep 03 06:29:04 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 10
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c2394-e38466da799f1c0e53019709b8ab132dbc2c5cb067f0b575e84b6506ef224fc43
OpenAccessLink https://www.jstage.jst.go.jp/article/jjoms1967/53/10/53_10_594/_article/-char/en
PageCount 9
ParticipantIDs crossref_citationtrail_10_5794_jjoms_53_594
crossref_primary_10_5794_jjoms_53_594
jstage_primary_article_jjoms1967_53_10_53_10_594_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2007
PublicationDateYYYYMMDD 2007-01-01
PublicationDate_xml – year: 2007
  text: 2007
PublicationDecade 2000
PublicationTitle Japanese Journal of Oral and Maxillofacial Surgery
PublicationTitleAlternate Jpn. J. Oral. Maxillofac. Surg.
PublicationYear 2007
Publisher Japanese Society of Oral and Maxillofacial Surgeons
Publisher_xml – name: Japanese Society of Oral and Maxillofacial Surgeons
References 15) Zarychanski, R., Elphee, E., et al.: Osteonecrosis of the jaw associated with Pamidronate therapy. Am J Hematol 81: 73-75 2006.
7) Marx, R. E., Sawatari, Y., et al.: Bisphosphonate-Induced exposed bone (Osteonecrosis/Osteoporosis) of the jaws: risk factor, recognition, prevention, and treatment. J Oral Maxillofac Surg 63: 1567-1575 2005.
10) Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws: American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws. J Oral Maxillofac Surg 65: 369-375 2007.
20) Harper, R. P and Fung, E. F.: Resolution of Bisphosphonate-associated osteonecrosis of the mandible: Possible application for intermittent low-dose parathyroid hormone (rhPTH (1-34). J Oral Maxillofac Surg 65: 573-580 2007.
1) Wang, J., Goodger, N. M., et al.: Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 61: 1104-1107 2003.
8) Ficarra, G., Beninati, F., et al.: Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment. J Clin Periodontol 32: 1123-1128 2005.
2) Marx, R. E.: Pamidronate (Media) and Zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg. 61: 1115-1118 2003.
6) Ruggiero, S. L., Mehrotra, B., et al.: Osteonecrosis of the jaws associated with the use of Bisphosphonates: A review of 63 cases. J Oral Maxillofac Surg. 62: 527-534 2004.
5) Thron, J. J., Hansen, H. S., et al.: Osteoradionecrosis of the jaws: Clinical characteristics and relation to the field of irradiation. J Oral Maxillofac Surg. 58: 1088 2000.
3) 高橋喜久雄, 川畑彰子, 他: ビスフォスフォネートによって発症したと考えられた上顎骨壊死の1例. 日口外誌 52: 416-419 2006.
14) Khamaisi, M., Regev, E., et al.: Possible association between diabetes and Bisphosphonate-related jaw osteonecrosis. J Clin Endocrinol Metab 92: 1172-1175 2007.
16) Bagan, J. V.: Jaw osteonecrosis associated with bisphosphonates: Multiple exposed areas and its relationship to teeth extractions. Study of 20 cases. Oral Oncol 42: 327-329 2006.
17) Gibbs, S. D. J., Grady, J. O., et al.: Bisphosphonateinduced osteonecrosis of the jaw requires early detection and intervention. Med J Australia 183: 549-550 2005.
19) Merigo, E., Manfredi, M., et al.: Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report. J Oral Pathol Med 34: 613-617 2005.
13) Purcell, P. M. and Boyd, I. W.: Bisphosphonate and osteonecrosis of the jaw. Med J Australia 182: 417-418 2005.
11) Dunstan, C. R., Felsenberg, D., et al.: Therapy Insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease. Nat Clin Pract Oncol 4: 42-55 2007.
9) Mavrokokki, T., Cheng, A., et al.: Nature and frequency of Bisphosphonate-Associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg. 65: 415-423 2007.
12) Farrugia, M. C., Summerlin, D. J., et al.: Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates. Larygoscope 116: 115-120 2006.
18) 浦出雅裕: ビスボスホネートと顎骨壊死. Clinical Calcium 17: 241-248 2007.
4) 岸直子, 足立忠文, 他: ビスフォスフォネートにより発症した下顎骨壊死の1例. 日口外誌 53: 28-32 2007.
References_xml – reference: 3) 高橋喜久雄, 川畑彰子, 他: ビスフォスフォネートによって発症したと考えられた上顎骨壊死の1例. 日口外誌 52: 416-419 2006.
– reference: 18) 浦出雅裕: ビスボスホネートと顎骨壊死. Clinical Calcium 17: 241-248 2007.
– reference: 14) Khamaisi, M., Regev, E., et al.: Possible association between diabetes and Bisphosphonate-related jaw osteonecrosis. J Clin Endocrinol Metab 92: 1172-1175 2007.
– reference: 19) Merigo, E., Manfredi, M., et al.: Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report. J Oral Pathol Med 34: 613-617 2005.
– reference: 5) Thron, J. J., Hansen, H. S., et al.: Osteoradionecrosis of the jaws: Clinical characteristics and relation to the field of irradiation. J Oral Maxillofac Surg. 58: 1088 2000.
– reference: 12) Farrugia, M. C., Summerlin, D. J., et al.: Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates. Larygoscope 116: 115-120 2006.
– reference: 8) Ficarra, G., Beninati, F., et al.: Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment. J Clin Periodontol 32: 1123-1128 2005.
– reference: 11) Dunstan, C. R., Felsenberg, D., et al.: Therapy Insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease. Nat Clin Pract Oncol 4: 42-55 2007.
– reference: 17) Gibbs, S. D. J., Grady, J. O., et al.: Bisphosphonateinduced osteonecrosis of the jaw requires early detection and intervention. Med J Australia 183: 549-550 2005.
– reference: 15) Zarychanski, R., Elphee, E., et al.: Osteonecrosis of the jaw associated with Pamidronate therapy. Am J Hematol 81: 73-75 2006.
– reference: 20) Harper, R. P and Fung, E. F.: Resolution of Bisphosphonate-associated osteonecrosis of the mandible: Possible application for intermittent low-dose parathyroid hormone (rhPTH (1-34). J Oral Maxillofac Surg 65: 573-580 2007.
– reference: 10) Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws: American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws. J Oral Maxillofac Surg 65: 369-375 2007.
– reference: 7) Marx, R. E., Sawatari, Y., et al.: Bisphosphonate-Induced exposed bone (Osteonecrosis/Osteoporosis) of the jaws: risk factor, recognition, prevention, and treatment. J Oral Maxillofac Surg 63: 1567-1575 2005.
– reference: 2) Marx, R. E.: Pamidronate (Media) and Zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg. 61: 1115-1118 2003.
– reference: 6) Ruggiero, S. L., Mehrotra, B., et al.: Osteonecrosis of the jaws associated with the use of Bisphosphonates: A review of 63 cases. J Oral Maxillofac Surg. 62: 527-534 2004.
– reference: 9) Mavrokokki, T., Cheng, A., et al.: Nature and frequency of Bisphosphonate-Associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg. 65: 415-423 2007.
– reference: 16) Bagan, J. V.: Jaw osteonecrosis associated with bisphosphonates: Multiple exposed areas and its relationship to teeth extractions. Study of 20 cases. Oral Oncol 42: 327-329 2006.
– reference: 4) 岸直子, 足立忠文, 他: ビスフォスフォネートにより発症した下顎骨壊死の1例. 日口外誌 53: 28-32 2007.
– reference: 13) Purcell, P. M. and Boyd, I. W.: Bisphosphonate and osteonecrosis of the jaw. Med J Australia 182: 417-418 2005.
– reference: 1) Wang, J., Goodger, N. M., et al.: Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 61: 1104-1107 2003.
SSID ssj0001742264
Score 1.6185935
Snippet Bisphosphonates are used for the management of bone metastatic disease and hypercalcemia caused by malignancy, as well as the treatment of osteoporosis....
SourceID crossref
jstage
SourceType Enrichment Source
Index Database
Publisher
StartPage 594
SubjectTerms bisphosphonate
bone metastasis
jaw bones
osteomyelitis
osteonecrosis
Title A survey of bisphosphonate-related osteomyelitis/osteonecrosis of the jaws
URI https://www.jstage.jst.go.jp/article/jjoms1967/53/10/53_10_594/_article/-char/en
Volume 53
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Japanese Journal of Oral and Maxillofacial Surgery, 2007/10/20, Vol.53(10), pp.594-602
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jj9MwFLbKwIELAgFi2JQDnKp0msTZbkSIqp1RqegihlNkO7amnbYZtQ2i_E3-EO_ZSaYRg2DgUKtNbcf1--q35C2EvIl8FQUBjW3G3cCmoWR2nAll0yxilMlYdCUa9Icfg_6Mnp77563WjwOvpWLHO-L7jXEl_0JVuAZ0xSjZW1C2nhQuwHugL7RAYWj_isZJe1tsvkr9kJzPt1cXOb7WID7aOkYFhEmM4chXe4lebkCynv68lsgcTSYSFDwXrBStKykVOChWpmwfiKujTZlVYMi-zZfLXDFtbJ8chFUjbsaDL6NJf6BPdrYt1vlmXtN0NB5ME21u3efb4rKGVG82nk2Sz_qrs_k-V8WqHjQYJmayYscuWcNGEV5zjmq9lQ_qH9bbNFGi-4jvlAeg1NewhJbt-KYATXWCm3TDFVK7B-exbyool6w90MHdv3ANmI0i11jkq23H9zr1oEYe7pLKqe4G51aY-l4KKlTZxjStemC8HMDzDrnrhqGDfqZnn6Jrw1-og5eN65H5fSYgA5dxcriIhqh0bwHaQuVpqIWf6UPyoISBlZhbPyItuX5MThPLwM_KlXUz_KwG_E4a4MNRAD4LwfeEzHofpu_7dlmawxauF1NbeiC3BhkL41g58H_2gU_EYTfmEeOO52ZcuMIXHEQh1eWgEciIctAFAqlAZFSCek_J0Rpu-IxYnvSFi3pHEAoqGWZnyryMKg6qfca63jFpV7uQijJvPZZPWepthz0zFEE6wJ4dk7d17yuTr-U3_d6ZDa173Zq-z_9_ihfkvnlWgCa9l-RotynkKxByd_y1Bs1PFCGyvQ
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+survey+of+bisphosphonate-related+osteomyelitis%2Fosteonecrosis+of+the+jaws&rft.jtitle=Japanese+Journal+of+Oral+and+Maxillofacial+Surgery&rft.au=ARIYOSHI%2C+Yasunori&rft.au=MORITA%2C+Syosuke&rft.au=FURUSAWA%2C+Kiyofumi&rft.au=IMAI%2C+Yutaka&rft.date=2007&rft.pub=Japanese+Society+of+Oral+and+Maxillofacial+Surgeons&rft.issn=0021-5163&rft.eissn=2186-1579&rft.volume=53&rft.issue=10&rft.spage=594&rft.epage=602&rft_id=info:doi/10.5794%2Fjjoms.53.594&rft.externalDocID=article_jjoms1967_53_10_53_10_594_article_char_en
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-5163&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-5163&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-5163&client=summon